Association of Helicobacter pylori infection with coronary heart disease. Eradication of the infection on grounds of cardiovascular risk is not supported by current evidence
Delaney, B.C.; Hobbs, F.D.; Holder, R.
Bmj 312(7025): 251-252
1996
ISSN/ISBN: 0959-8138 PMID: 8563611 Document Number: 457189
Document emailed within 1 workday
Related Documents
Lip, G.H.; Wise, R.; Beevers, G. 1996: Association of Helicobacter pylori infection with coronary heart disease. Study shows association between H pylori infection and hypertension Bmj 312(7025): 250-251Kowalski, M. 2001: Helicobacter pylori (H. pylori) infection in coronary artery disease: influence of H. pylori eradication on coronary artery lumen after percutaneous transluminal coronary angioplasty. the detection of H. pylori specific DNA in human coronary atherosclerotic plaque Journal of Physiology and Pharmacology An Official Journal of the Polish Physiological Society 52(1 Suppl 1): 3-31
Patel, P.; Mendall, M.A.; Carrington, D.; Strachan, D.P.; Leatham, E.; Molineaux, N.; Levy, J.; Blakeston, C.; Seymour, C.A.; Camm, A.J. 1995: Association of Helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors BMJ 311(7007): 711-714
Ponzetto, A.; La Rovere, M.T.; Sanseverino, P.; Bazzoli, F. 1996: Association of Helicobacter pylori infection with coronary heart disease. Study confirms previous findings Bmj 312(7025): 251
Koizumi, W.; Tanabe, S.; Imaizumi, H.; Hibi, K-ichi.; Kida, M.; Ohida, M.; Okayasu, I.; Saigenji, K. 2003: Effect of anti-Helicobacter pylori IgG antibody titer following eradication of Helicobacter pylori infection Hepato-Gastroenterology 50(49): 293-296
Lou, J-gan.; Chen, J.; Huang, X-lei.; Zhao, Z-yan. 2007: Changes in the intestinal microflora of children with Helicobacter pylori infection and after Helicobacter pylori eradication therapy Chinese Medical Journal 120(10): 929-931
Chang, Y-Ting.; Wu, M-Shiang.; Shun, C-Tung.; Lin, M-Tsan.; Chang, M-Chu.; Lin, J-Town. 2002: Association of polymorphisms of interleukin-1 beta gene and Helicobacter pylori infection with the risk of gastric ulcer Hepato-Gastroenterology 49(47): 1474-1476
Boixeda De Miquel, D.; Martín De Argila, C. 2002: Current therapy of Helicobacter pylori infection in peptic ulcer disease (first part) Revista Clinica Espanola 202(9): 492-494
Chung, S.Jin.; Lee, D.Ho.; Kim, N.; Jung, S.Hyang.; Kim, J.Wook.; Hwang, J.Hyeok.; Park, Y.Soo.; Lee, K.Hyuk.; Jung, H.Chae.; Song, I.Sung. 2007: Eradication rates of helicobacter pylori infection with second-line treatment: non-ulcer dyspepsia compared to peptic ulcer disease Hepato-Gastroenterology 54(76): 1293-1296
Lin, J.T.; Wang, L.Y.; Wang, J.T.; Wang, T.H.; Yang, C.S.; Chen, C.J. 1995: A nested case-control study on the association between Helicobacter pylori infection and gastric cancer risk in a cohort of 9775 men in Taiwan Anticancer Research 15(2): 603-606
Wyrobiec, G.; Helewski, K.; Stepień, M. 2001: Ischaemic heart disease and chronic helicobacter pylori infection--present views Wiadomosci Lekarskie 54(11-12): 684-692
Fradkin, A.; Yahav, Y.; Diver-Haber, A.; Weisselberg, B.; Jonas, A. 1997: The value of anti-Helicobacter pylori IgG antibodies in establishing eradication of infection in children Israel Journal of Medical Sciences 33(2): 87-92
Katicić, M.; Banić, M.; Urek, M.Crncević.; Gasparov, S.; Krznarić, Z.; Prskalo, M.; Stimac, D.; Skrtić, A.; Vucelić, B. 2014: Croatian guidelines for gastric cancer prevention by eradication of Helicobacter pylori infection Lijecnicki Vjesnik 136(3-4): 59-68
Romero Gómez, M.; Martínez Delgado, C.; Grande, L.; Otero Fernández, M.A.; Vargas, J.; Castro Fernández, M. 2000: Intravenous eradication therapy for bleeding gastroduodenal ulcer associated with Helicobacter pylori infection Revista Espanola de Enfermedades Digestivas: Organo Oficial de la Sociedad Espanola de Patologia Digestiva 92(6): 386-391
Unger, Z.; Prónai, L.; Szaleczky, E.; Zágoni, T.; Molnár, B.; Tulassay, Z. 2000: Effect of Helicobacter pylori infection and eradication on proliferative kinetics of the gastric mucosa Orvosi Hetilap 141(50): 2695-2700
Uthaisaengsook, W. 2003: Low dose, one-week triple therapy (lanzoprazole, amoxycillin, clarithromycin) for eradication of Helicobacter pylori infection Journal of the Medical Association of Thailand 86(7): 599-602
Brzozowski, T.; Konturek, P.C.; Kwiecien, S.; Konturek, S.J.; Pajdo, R.; Drozdowicz, D.; Ptak, A.; Pawlik, M.; Stachura, J.; Pawlik, W.W.; Hahn, E.G. 2003: Triple eradication therapy counteracts functional impairment associated with Helicobacter pylori infection in Mongolian gerbils Journal of Physiology and Pharmacology: An Official Journal of the Polish Physiological Society 54(1): 33-51
Chen, T.; Jin, R.; Huang, Z.; Hong, W.; Chen, Z.; Wang, J. 2014: The variation of expression of CD4+ CD25+ Foxp3+ regulatory T cells in patients with Helicobacter pylori infection and eradication Hepato-Gastroenterology 61(130): 507-511
Santolaria, S.; Lanas A; Benito, R.; Piazuelo, E.; Sáinz, R. 2001: CagA and VacA cytotoxin antibodies and risk for peptic ulcer disease in patients with Helicobacter pylori infection Medicina Clinica 116(17): 641-644
Mascellino, M.T.; Oliva, A.; De Angelis, M.; Pontone, S.; Porowska, B. 2018: Helicobacter pylori infection: antibiotic resistance and eradication rate in patients with gastritis showing previous treatment failures New Microbiologica 41(4): 306-309